Penumbra, Inc Cash and Restricted Cash
Penumbra, Inc (PEN) had Cash and Restricted Cash of $205.27 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $205.27M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $241.29M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $186.90M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $321.03M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $205.27M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $241.29M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $186.90M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $321.03M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $421.77M 10-Q · filed 2026-07-30 |
| 2025-03-31 | $376.05M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $324.40M 10-Q · filed 2026-07-30 |
| 2024-09-30 | $280.48M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $288.33M 10-Q · filed 2025-07-29 |
| 2024-03-31 | $223.11M 10-Q · filed 2025-04-23 |
| 2023-12-31 | $167.49M 10-K · filed 2026-02-25 |
| 2023-09-30 | $100.76M 10-Q · filed 2024-10-30 |
| 2023-06-30 | $114.17M 10-Q · filed 2024-07-30 |
| 2023-03-31 | $94.69M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $69.86M 10-K · filed 2026-02-25 |
| 2022-09-30 | $54.84M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $58.23M 10-Q · filed 2023-08-01 |
| 2022-03-31 | $68.16M 10-Q · filed 2023-05-02 |
| 2021-12-31 | $59.38M 10-K · filed 2025-02-18 |
| 2021-09-30 | $66.29M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $82.28M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $55.63M 10-Q · filed 2022-05-03 |
| 2020-12-31 | $69.67M 10-K · filed 2024-02-22 |
| 2020-09-30 | $80.11M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $134.38M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $72.46M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $72.78M 10-K · filed 2023-02-23 |
| 2019-09-30 | $111.58M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $77.26M 10-Q · filed 2020-08-03 |
| 2019-03-31 | $95.61M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $67.85M 10-K · filed 2022-02-22 |
| 2018-09-30 | $47.74M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $59.70M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $52.80M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $50.64M 10-K · filed 2021-02-23 |
| 2017-09-30 | $65.62M 10-Q · filed 2018-11-05 |
| 2017-06-30 | $78.39M 10-Q · filed 2018-08-07 |
| 2017-03-31 | $111.09M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $13.24M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |